Nouveau médicament coréen contre la LMC
"The new drug is likely to bring a huge change to the anti-leukemia medicine market,
as patients here have had access to only imported drugs costing 70 to 100 billion won per year.
There are about 2,300 chronic myeloid leukemia patients in Korea, with some 300 new patients being diagnosed every year."
Extrait de http://www.koreatimes.co.kr/www/news/na ... 49374.html